Theravance Biopharma, Inc. (TBPH)
14.68
-0.07
(-0.47%)
USD |
NASDAQ |
Mar 24, 10:02
Theravance Biopharma Price : 14.68 for March 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Integer Holdings Corp. | 84.11 |
| QuidelOrtho Corp. | 16.65 |
| Viatris, Inc. | 13.22 |
| Catalyst Pharmaceuticals, Inc. | 23.07 |
| Nektar Therapeutics | 72.12 |
Price Related Metrics
| PE Ratio | 7.240 |
| PS Ratio | 7.014 |
| Price to Book Value | 2.527 |
| Price to Free Cash Flow | 3.161 |
| Earnings Yield | 13.81% |
| Market Cap | 749.69M |
| Normalized PE Ratio | 7.240 |